Welcome to our dedicated page for Avantor news (Ticker: AVTR), a resource for investors and traders seeking the latest updates and insights on Avantor stock.
Avantor, Inc. reports developments as a life science tools company supplying mission-critical products and services to life sciences and advanced technology customers through its VWR Distribution & Services and Bioscience & Medtech Products businesses. Recurring updates cover earnings, cash flow, leverage, guidance, segment performance and the company’s Revival transformation program, including VWR brand activity, manufacturing and supply-chain improvements and e-commerce upgrades.
Company news also covers portfolio and infrastructure actions such as Masterflex fluid handling systems, single-use assemblies, peristaltic pumps, J.T. Baker high-purity process chemicals, and expanded microbial and stability testing capabilities for regulated biopharma manufacturing. Governance and management updates include finance leadership changes and appointments tied to bioscience, medtech products and enterprise transformation.
Avantor (NYSE: AVTR) has announced the appointment of Corey Walker as President of its Laboratory Solutions business, effective June 21, 2024. Walker, who has previously held senior roles at Avantor and was most recently CEO of ILC Dover, brings extensive expertise in life sciences and advanced technologies. He will report to CEO Michael Stubblefield. Walker succeeds Randy Stone, who made significant contributions to the Laboratory Solutions segment. Avantor's new operating model, featuring two global segments – Laboratory Solutions and Bioscience Production – became effective in January 2024. The company reaffirms its fiscal year 2024 guidance as previously stated during its Q1 earnings call.
Avantor (NYSE: AVTR) released its 2024 Sustainability Report, detailing significant progress in 2023 across four key pillars: People & Culture, Innovation & Environment, Community Engagement, and Governance & Integrity.
Notably, Avantor met its 2025 greenhouse gas emissions reduction target two years early, achieving a 16.7% decrease from 2019 levels. The company has set new targets for 2030. Avantor earned a top score on the Human Rights Campaign's 2023 Corporate Equality Index and awarded over $1.2 million in grants for healthcare and STEM education. Additionally, Avantor launched a Responsible Supplier Program, enrolling 340 suppliers.
Avantor (NYSE: AVTR), a global provider of mission-critical products in life sciences and advanced technologies, announced that its President and CEO, Michael Stubblefield, will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference. This event will take place on June 11, 2024, at 11:20 a.m. Eastern Time in Miami, Fla. A live audio webcast of the session will be available on the Avantor website, and a replay will be accessible for 30 days.
Avantor has announced that its President and CEO, Michael Stubblefield, will participate in a fireside chat at Bernstein's 40th Annual Strategic Decisions Conference. The event will take place in New York on May 30, 2024, at 8:00 a.m. Eastern Time. Attendees can listen to a live audio webcast of the session via the Investor section of Avantor's website. A replay will be accessible for 30 days following the event.
Avantor, Inc. (NYSE: AVTR) will have its President and CEO, Michael Stubblefield, participating in a fireside chat at the BofA Securities 2024 Health Care Conference in Las Vegas on May 14, 2024. Investors can access the live audio webcast on Avantor's website and a replay will be available for 30 days.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.